20-Year prevalence projections for dementia and impact of preventive policy about risk factors

Hélène Jacqmin-Gadda,Annick Alperovitch,Claire Montlahuc,Daniel Commenges,Karen Leffondre,Carole Dufouil,Alexis Elbaz,Christophe Tzourio,Joël Ménard,Jean-François Dartigues,Pierre Joly

DOI: https://doi.org/10.1007/s10654-013-9818-7

2013-06-01

European Journal of Epidemiology

Abstract:Incidence of dementia increases sharply with age and, because of the increase in life expectancy, the number of dementia cases is expected to rise dramatically over time. Some studies suggest that controlling some modifiable risk factors for dementia like diabetes or hypertension could lower its incidence. However, as treating these vascular factors would also reduce mortality risk, the actual impact of such public-health intervention on dementia prevalence is not known. Accounting for the impact of dementia and risk factors on mortality, the aim of this work was (1) to compute projections of age- and-sex specific prevalence of dementia in France from 2010 to 2030, (2) to evaluate how public-health interventions targeting risk factors for dementia could change these projections. Age-and-sex specific incidence of dementia and mortality of demented subjects were estimated from the Paquid population-based cohort using a semi-parametric illness-death model. Future global mortality rates and population sizes were obtained from national demographic projections. Under the assumption that life expectancy will increase by 3.5 years for men and 2.8 years for women by 2030, the number of subjects with dementia was estimated to increase by about 75 % from 2010 to 2030 with a 200 % increase after 90 years of age. Therapeutic intervention on the whole population reducing high blood pressure prevalence would lead to a decrease in both dementia incidence rates and mortality and would have a modest impact on the number of dementia cases. On the other hand, a preventive dementia treatment targeting ApoE4 carriers would probably not improve survival and hence would decrease dementia prevalence by 15–25 %.

public, environmental & occupational health

What problem does this paper attempt to address?

This paper aims to solve the following two main problems:

1. **Calculate the age - and gender - specific prevalence of dementia in France from 2010 to 2030**:
- By using a multi - state model and considering the mortality differences between the general population and the non - demented population, the paper estimates the prevalence of dementia in France in the next 20 years. Specifically, the paper uses a three - state illness - death model: healthy (i.e., alive and without dementia), demented (alive), and dead. The transition intensities in the model represent the risk of a healthy individual developing dementia, the risk of death for a healthy individual, and the risk of death for a demented patient, respectively.

2. **Evaluate the impact of public health interventions targeting dementia risk factors on these prevalence predictions**:
- The paper explores the impact of different intervention scenarios, such as controlling hypertension (HBP) and preventive treatment for APOE4 gene carriers, on the prediction of dementia prevalence. Specific assumptions include:
- **Assumption 4**: Risk factors cannot be changed after the age of 65.
- **Assumption 5**: There is a proportional intensities assumption between risk factors and the risk of dementia and the risk of death.

### Main findings

- **Growth in dementia prevalence**:
- According to the central life - expectancy scenario, by 2030, the number of female dementia patients aged 65 - 99 in France is expected to reach 1,146,000, and 604,000 for men. Overall, from 2010 to 2030, the number of dementia cases is expected to increase by 75.7%.
- The increase in dementia prevalence is particularly significant in the elderly population, especially those over 90 years old, with an expected increase of 208%.

- **Impact of public health interventions**:
- **Controlling hypertension**:
- If the prevalence of hypertension at the age of 65 is reduced by half, the impact on the prevalence of dementia is very limited (a reduction of about 1.4%). However, if an antihypertensive drug can reduce the risk of dementia in hypertensive patients by 15% and the risk of death by 43% at the same time, it will increase the prevalence of dementia in the 65 - 85 - year - old population by 5.6% in 2030.
- **Preventive treatment for APOE4 gene carriers**:
- If the risk of dementia in APOE4 gene carriers can be reduced by 50%, the prevalence of dementia can be significantly reduced (by 15% - 25%).

### Conclusion

Through detailed models and data analysis, the paper shows the growth trend of the prevalence of dementia in France in the next 20 years and evaluates the effects of different public health interventions. These results are of great significance for formulating effective public health policies, especially in dealing with the challenges brought by population aging.